Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Herbal Medicinals committee

This article was originally published in The Tan Sheet

Executive Summary

First meeting of the European Union's Committee on Herbal Medicinal Products will take place Sept. 23 in Canary Wharf, London. Members of the European Commission, European Parliament and commitee chairman will speak, after which attendees may participate in a Q&A session. The committee was formed as part of Directive 2004/24/EC, which "helps to clarify and streamline rules for marketing of herbal medicines in the European Union [and] also establishes a simplified procedure for registration of traditional herbal medicines within the Community" (1"The Tan Sheet" June 21, 2004, p. 13)...

You may also be interested in...



European Herbal Medicinal Products Committee To Convene In September

The European Union's newly established herbal medicines committee's primary task will be implementing legislation on traditional medicine that went into effect in April

Amgen/AstraZeneca’s Tezepelumab Cuts Asthma Exacerbations By 56%

Data presented at AAAI meeting show reduced annualized asthma exacerbation rates across all patient populations, but doctors are unlikely to switch patients served well by existing biologics. 

Sarepta’s Next-Generation Drugs Draw Attention Amid ‘Incremental’ Approval

The RNA drug’s accelerated approval brings Sarepta’s exon-skipping market share to nearly 30%.

Topics

UsernamePublicRestriction

Register

IV001392

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel